Patent protection of amino acid and nucleic acid sequences

Aside from the current Brazilian Industrial Property Law No. 9.279/1996, Resolution PR No. 81/2013, that sets out the procedures for the submission of “sequence listings”, and the Guidelines for the Examination of Patent Applications, there are also guidelines in the areas of biotechnology and pharmaceuticals in Brazil.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

Patent protection of amino acid and nucleic acid sequences

Editor's picks

Editor's picks

More features